Literature DB >> 26687374

Two cases of immune thrombocytopenia associated with pembrolizumab.

Audrey Le Roy1, Emmanuelle Kempf2, Felix Ackermann3, Emilie Routier4, Caroline Robert5, Anthony Turpin6, Aurélien Marabelle6, Christine Mateus4, Jean-Marie Michot7, Olivier Lambotte8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26687374     DOI： 10.1016/j.ejca.2015.10.073

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  19 in total

Review 1.  Checkpoint Inhibitors.

Authors:  Lucie Heinzerling; Enrico N de Toni; Georg Schett; Gheorghe Hundorfean; Lisa Zimmer
Journal:  Dtsch Arztebl Int       Date:  2019-02-22       Impact factor: 5.594

2.  Pembrolizumab-Induced Pancytopenia: A Case Report.

Authors:  Dinesh Atwal; Krishna P Joshi; Rahul Ravilla; Fade Mahmoud
Journal:  Perm J       Date:  2017

Review 3.  Severe Thrombocytopenia Associated With Pembrolizumab in Patients With Non-small Cell Lung Cancer (NSCLC): A Case Report and Literature Review.

Authors:  Atsuto Mouri; Kyoichi Kaira; Ayako Shiono; Y U Miura; Hiroshi Kagamu
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

4.  Rare case of life-threatening thrombocytopenia occurring after radiotherapy in a patient treated with immune checkpoint inhibitor.

Authors:  Aurore Hendrix; Anne-Emmanuella Yeo; Sarah Lejeune; Emmanuel Seront
Journal:  BMJ Case Rep       Date:  2020-06-09

5.  Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy.

Authors:  Eileen Shiuan; Kathryn E Beckermann; Alpaslan Ozgun; Ciara Kelly; Meredith McKean; Jennifer McQuade; Mary Ann Thompson; Igor Puzanov; John P Greer; Suthee Rapisuwon; Michael Postow; Michael A Davies; Zeynep Eroglu; Douglas Johnson
Journal:  J Immunother Cancer       Date:  2017-02-21       Impact factor: 13.751

6.  An Episode of Pseudothrombocytopenia during Pembrolizumab Therapy in NSCLC Patient.

Authors:  Kinga Krukowska; Robert Kieszko; Katarzyna Kurek; Izabela Chmielewska; Paweł Krawczyk; Janusz Milanowski
Journal:  Case Rep Oncol Med       Date:  2020-05-08

7.  A Case of Immune Thrombocytopenia as a Rare Side Effect of an Immunotherapy with PD1-Blocking Agents for Metastatic Melanoma.

Authors:  Claudia Pföhler; Hermann Eichler; Barbara Burgard; Nathalie Krecké; Cornelia S L Müller; Thomas Vogt
Journal:  Transfus Med Hemother       Date:  2017-09-14       Impact factor: 3.747

8.  Drug-induced immune-mediated thrombocytopenia secondary to durvalumab use.

Authors:  Sean C Dougherty; Alia C Lynch; Richard D Hall
Journal:  Clin Case Rep       Date:  2021-06-22

9.  Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab.

Authors:  Andrew Hantel; Brooke Gabster; Jason X Cheng; Harvey Golomb; Thomas F Gajewski
Journal:  J Immunother Cancer       Date:  2018-07-16       Impact factor: 13.751

10.  Pembrolizumab-induced pancytopenia in a patient with squamous cell lung cancer.

Authors:  Yuriko Ueki; Manabu Suzuki; Yuriko Horikawa; Hiromu Watanabe; Yoh Yamaguchi; Chie Morita; Akinari Tsukada; Hiroshi Takumida; Yusaku Kusaba; Takashi Katsuno; Yoshie Tsujimoto; Keita Sakamoto; Masao Hashimoto; Junko Terada; Satoru Ishii; Jin Takasaki; Go Naka; Motoyasu Iikura; Shinyu Izumi; Yuichiro Takeda; Masayuki Hojo; Haruhito Sugiyama
Journal:  Thorac Cancer       Date:  2020-08-07       Impact factor: 3.500
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.